Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is A two-arm, open-label, single-sequence, multiple oral dosings, crossover study to evaluate the safety and the pharmacokinetic interaction of DWC202313 and DWC202314 in healthy adult volunteers.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| DWC202313 | Experimental | DWC202313 |
|
| DWC202314 | Experimental | DWC202314 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DWC202313 | Drug | Experimental Drug 1 |
| |
| DWC202314 |
| Measure | Description | Time Frame |
|---|---|---|
| Cmax,ss of DWC202313 and DWC202314 | Up to 14 days | |
| AUCt,ss of DWC202313 and DWC202314 | Up to 14 days |
| Measure | Description | Time Frame |
|---|---|---|
| Tmax,ss of DWC202313 and DWC202314 | Up to 14 days | |
| Cmin,ss of DWC202313 and DWC202314 | Up to 14 days | |
| t1/2 of DWC202313 and DWC202314 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Seung-Hyun Kang, MD, Ph D | Contact | 070-4665-9490 | juspa@newyjh.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| H Plus YANGJI Hospital | Recruiting | Seoul | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
Experimental Drug 2 |
|
| Up to 14 days |
| CLss/F of DWC202313 and DWC202314 | Up to 14 days |
| Vdss/F of DWC202313 and DWC202314 | Up to 14 days |
| PTF of DWC202313 and DWC202314 | Up to 14 days |